Evidence map›Paper›PMID 38519916›Full record

SynthesisBMC infectious diseases2024

Clinical characteristics, diagnosis, treatment, and outcome of patients with liver abscess due to Aspergillus spp: a systematic review of published cases.

Igor Dumic, Enzo Marasco Caetano, Sidney Marcel Domingues, Ivana Pantic, Milan Radovanovic, Libardo Rueda Prada, Charles W Nordstrom, Marina Antic, Tamara Milovanovic, Magdalena Kotseva and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Pulmonary Artery Mass Caused byInfectious disease reports · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. A rare case of hepatic abscess due toSAGE open medical case reports · 2026
    Article
  8. Aeromonas caviae: A rare case of hepatic abscess.GMS hygiene and infection control · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Case report: Trauma-inducedFrontiers in medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Igor DumicMayo Clinic College of Medicine and Science, Rochester, MN, USA. Dumic.Igor@mayo.edu.
Enzo Marasco CaetanoMunicipal University of São Caetano do Sul, Sao Paulo, Brazil.
Sidney Marcel DominguesMunicipal University of São Caetano do Sul, Sao Paulo, Brazil.
Ivana PanticClinic for Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia.
Milan RadovanovicMayo Clinic College of Medicine and Science, Rochester, MN, USA.
Libardo Rueda PradaMayo Clinic College of Medicine and Science, Rochester, MN, USA.
Charles W NordstromMayo Clinic College of Medicine and Science, Rochester, MN, USA.
Marina AnticMayo Clinic College of Medicine and Science, Rochester, MN, USA.
Tamara MilovanovicClinic for Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia.
Magdalena KotsevaInternal Medicine Residency Program, Franciscan Health, Olympia Fields, IL, USA.
Amteshwar SinghDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Shweta FnuMayo Clinic College of Medicine and Science, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAspergillus spp liver abscess is a relatively rare entity and thus far no systematic review has been performed examining patients' demographics, clinical manifestations, diagnosis, management, and outcome.

methodsWe performed a systematic review of the literature using MEDLINE and LILACS databases. We searched for articles published in the period from January 1990 to December 24, 2022, to identify patients who developed liver abscesses due to Aspergillus spp.

resultsOur search yielded 21 patients all of whom had invasive aspergillosis confirmed on liver biopsy. Of these patients 81% were adults, and 60% were males. The majority (86%) of patients were immunocompromised and 95% had symptomatic disease at the time of diagnosis. The most common symptoms were fever (79%), abdominal pain (47%), and constitutional symptoms (weight loss, chills, night sweats, fatigue) (38%). Liver enzymes were elevated in 50%, serum galactomannan was positive in 57%, and fungal blood cultures were positive in only 11%. Co-infection with other pathogens preceded development of apsergillosis in one-third of patients, and the majority of the abscesses (43%) were cryptogenic. In the remaining patients with known source, 28% of patients developed liver abscess through dissemination from the lungs, 19% through the portal vein system, and in 10% liver abscess developed through contiguous spread. The most common imaging modality was abdominal computerized tomography done in 86% of patients. Solitary abscess was present in 52% of patients while 48% had multiple abscesses. Inadequate initial empiric therapy was prescribed in 60% of patients and in 44% of patients definite treatment included combination therapy with two or more antifungal agents. Percutaneous drainage of the abscesses was done in 40% of patients, while 20% required liver resection for the treatment of the abscess. Overall mortality was very high at 38%.

conclusionFurther studies are urgently needed for a better understanding of pathophysiology of liver aspergillosis and for developement of newer blood markers in order to expedite diagnosis and decrease mortality.

Indexed as

Antifungal AgentsAspergillosisAspergillusLiver AbscessAdultFemaleHumansImmunocompromised HostMaleMiddle AgedTreatment OutcomeAntifungal AgentsAspergillusImmunosupressionLiver abscess

Identifiers

PMID38519916
PMCPMC10960385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.